Aeglea BioTherapeutics, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Aeglea BioTherapeutics, Inc.
CIK #0001636282
EDGAR Form CIK 2011 - 2025
10-K [0001636282]
10-Q [0001636282]
3 [0001636282]
4 [0001636282]
5 [0001636282]
8-K [0001636282]
D [0001636282]
SC 13D [0001636282]
SC 13G [0001636282]
Form 13D/13G Filer Form 13D/13G Subject Filed
Vanguard Group Inc Spyre Therapeutics Inc [2025-07-29]
Tang Capital Management LLC Spyre Therapeutics Inc [2025-05-01]
BlackRock Inc Spyre Therapeutics Inc [2024-11-08]
Deutsch Peter E Spyre Therapeutics Inc [2024-10-23]
BlackRock Inc Spyre Therapeutics Inc [2024-10-22]
RTW Investments LP Spyre Therapeutics Inc [2024-02-14]
Avoro Capital Advisors LLC Spyre Therapeutics Inc [2024-02-14]
FMR LLC Spyre Therapeutics Inc [2024-02-09]
Perceptive Advisors LLC Spyre Therapeutics Inc [2023-12-13]
Commodore Capital LP Spyre Therapeutics Inc [2023-12-01]
Deutsch Peter E Aeglea Biotherapeutics Inc [2023-11-14]
Polar Capital Holdings PLC Aeglea Biotherapeutics Inc [2023-07-28]
Logos Global Management LP Aeglea Biotherapeutics Inc [2023-07-18]
Venrock Healthcare Capital Partners III LP Aeglea Biotherapeutics Inc [2023-07-10]
Affinity Asset Advisors LLC Aeglea Biotherapeutics Inc [2023-07-03]
EcoR1 Capital Fund Qualified LP Aeglea Biotherapeutics Inc [2023-06-30]
Fairmount Funds Management LLC Aeglea Biotherapeutics Inc [2023-06-30]
Deep Track Capital LP Aeglea Biotherapeutics Inc [2023-06-30]
Rock Springs Capital Management LP Aeglea Biotherapeutics Inc [2023-02-14]
Baker Bros Advisors LP Aeglea Biotherapeutics Inc [2023-02-14]
Pictet Asset Management Sa Aeglea Biotherapeutics Inc [2023-02-03]
Integrated Core Strategies US LLC Aeglea Biotherapeutics Inc [2022-12-01]
BlackRock Inc Aeglea Biotherapeutics Inc [2022-06-09]
Nantahala Capital Management LLC Aeglea Biotherapeutics Inc [2022-02-14]
Pictet Asset Management Sa Aeglea Biotherapeutics Inc [2022-02-10]
Suvretta Capital Management LLC Aeglea Biotherapeutics Inc [2021-12-16]
Baker Bros Advisors LP Aeglea Biotherapeutics Inc [2021-03-05]
Lilly Ventures Fund I LLC Aeglea Biotherapeutics Inc [2021-02-12]
Pictet Asset Management Sa Aeglea Biotherapeutics Inc [2021-02-10]
BlackRock Inc Aeglea Biotherapeutics Inc [2021-02-02]
Point72 Asset Management LP Aeglea Biotherapeutics Inc [2020-10-26]
BCLS II Equity Opportunities LP Aeglea Biotherapeutics Inc [2020-06-09]
BlackRock Inc Aeglea Biotherapeutics Inc [2019-02-08]
Adage Capital Partners GP LLC Aeglea Biotherapeutics Inc [2018-10-11]
Baker Bros Advisors LP Aeglea Biotherapeutics Inc [2018-02-13]
Nantahala Capital Management LLC Aeglea Biotherapeutics Inc [2017-12-08]
Lilly Ventures Fund I LLC Aeglea Biotherapeutics Inc [2017-02-14]
Prudential Financial Inc Aeglea Biotherapeutics Inc [2016-05-10]
Jennison Associates LLC Aeglea Biotherapeutics Inc [2016-05-09]
OrbiMed Advisors LLC Aeglea Biotherapeutics Inc [2016-04-18]
Novartis BioVentures Ltd Aeglea Biotherapeutics Inc [2016-04-14]
Form 3/4/5 Subject 2011 - 2025
Stelzer Laurie
Spyre Therapeutics, Inc.
Fairmount Funds Management LLC
Harwin Peter Evan
Kiselak Tomas
Fairmount Healthcare Fund II L.P.
Albers Jeffrey W.
Henderson Michael Thomas
McKenna Mark C.
Milligan Sandra
View All
Terms | Privacy | Guide
tony@aum13f.com